Experiences Using GLP-1 Receptor Agonists in People with Dementia

We are exploring how GLP-1 receptor agonist medications (such as Ozempic, Trulicity, Mounjaro or Saxenda) may affect appetite and eating in people living with dementia. We would like to hear directly from people with dementia and their care partners about their experiences.

People who meet the following criteria may be eligible to take part in this study. 

• Aged 50 years or over
• Living with mild to moderate dementia
• Currently taking a GLP-1 medication for at least four weeks
• Living at home or in a retirement village in the ACT or NSW
• Able to take part in an interview in English or Chinese

Participation involves a single interview of approximately 30–45 minutes. Interviews can be held face-to-face at the University of Canberra Hospital, or online if preferred. Questions focus on appetite, eating habits and meals since starting a GLP-1 medication. A care partner is welcome to attend and contribute.